Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
With a new year swiftly coming, Steve Miranda, Executive Vice President, Applications Development at Oracle, recently joined the CRM Playaz to discuss what the year ahead has in store in the ...
1 Day ORCL 1.10% DJIA 0.60% S&P 500 0.32% Technology 0.29% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the ...
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback